News stories
FILTER:
-
Important negotiations on medicines provision about to start
Dr Tom Nutt, has stressed the importance of negotiations about to start between the Association of the British Pharmaceutical Industry (ABPI) and Government for a sustainable approach to medicines provision -
Tom’s 2022 Meningitis Now round-up
Thankfully, there is a very real sense now that we have returned to ‘normality’ at Meningitis Now, whilst recognising there are still real challenges ahead of us -
Recovery, rebuilding and a new sense of resolve
We’ve published our latest annual report for the year ending March 2022 -
Founder Steve Dayman to step back from Meningitis Now
At the end of March 2023, Steve Dayman will leave Meningitis Now at the culmination of Spencer’s Legacy: nobody left behind -
Two important studies show the positive impact of MenACWY vaccine in teenagers
We’ve welcomed the publication of research findings from a large-scale study that examined the impact of the UK’s MenACWY vaccination programme -
Survey hopes to bring improvements to meningitis aftercare and support
We’re after your help please to be part of an important national survey, which we hope will help to improve the aftercare and support provided to people who have been diagnosed with meningitis and have spent time in hospital -
Award for key contributions to vaccine development
Our congratulations to Professor Richard Moxon, a long-standing associate of Meningitis Now, who has been officially recognised for his key contributions to the development of meningitis vaccines -
New pneumococcal meningitis research project gets underway
We're delighted to announce that we've reinstated funding for a major research project into developing an improved vaccine against pneumococcal meningitis -
Understanding experiences and support needs of adults after meningitis
Our new survey focuses on the recovery and outcomes of UK adults aged 16 and over who have been hospitalised in the last five years with viral or bacterial meningitis -
A year like no other - Meningitis Now's annual report
The financial year 2020-21 presented a great number of unprecedented challenges for Meningitis Now. But as we look to the future, we have reasons to remain optimistic -
Uncertainty around accessing medical care for illnesses including meningitis
The findings of a recent survey emphasises the need for easy access to reliable, consistent information when a child is unwell or injured -
Meningitis Now's CEO joins new pharmaceutical industry advisory council
Tom Nutt is one of eight leaders of the new council, which aims to ensure a more patient-centric strategy, policy and priorities -
Missed opportunities for earlier treatment of illnesses including meningitis identified
The Before Arrival at Hospital (BeArH) project explored factors affecting the timing of admission to hospital for children with a serious infectious illness such as meningitis -
The story of meningitis and its prevention
Brain Fever, a new book by Professor Richard Moxon, is the engaging story of how chance, opportunity and passion drew him into researching the bacteria responsible for the deadly disease -
Meningitis Now support proposal to preserve charity-funded medical research
We are asking our MP contacts to support a proposal that will allow charities to continue their significant contribution to medical research and innovation -
The importance of clinical trials
Yesterday (20 May) was International Clinical Trials Day – a day that aims to raise awareness of the importance and value of clinical trials -
Meningitis Now partner with University of Plymouth for important study
Has ‘Stay Home’ advice delayed treatment for children? Meningitis Now have partnered with the University of Plymouth for this important study. -
Research underway to develop a new test for meningitis
A rapid test to diagnose severe illnesses, including meningitis, is being developed by scientists at Imperial College London -
Meningitis Now amongst organisations analysed in UK health research funding
A report published today, based on data from organisations including Meningitis Now, provides the most comprehensive analysis of UK health research funding ever -
Granddaughter of Meningitis Now founder joins the fight against the disease
Clemence, the 3-month-old granddaughter of our founder Steve, is taking part in a study for a new vaccine against MenACWY